Alibaba and Ping An-backed Prenetics is set to complete a reverse merger at a $1.25bn valuation. Exits from the broader genetics and gene therapeutics space appear to be in the middle of a valuation spike, according to our data.

Conductive Ventures returned for online savings platform developer Self Financial's $50m series E round while EV producer Volta Trucks completed its $43.6m series B.

Digital mental health platform Spring Health was valued at $2bn through a series C round backed by strategic investor Guardian Life.

The endocrine disease treatment developer pushed its overall funding past $160m in a round featuring Novo, Sham and Mass General Brigham.

Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.

Immutable, Abra and Francis Medical have all raised more than $50m, while MAZ Systems has been acquired by Zype.

Alibaba and Ping An-backed genetic testing services provider Prenetics will hold a reverse merger at a $1.25bn valuation, securing $120m in Pipe financing.

Sanofi Ventures, Mass General Brigham Ventures, GV and Alexandria Venture Investments have contributed to a $77m round for Rome Therapeutics.

Online furniture retailer Gaia, warehouse robot provider Locus Robotics, recruitment platform developer Canvas and ESG software producer Measurabl all raised $50m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.